News

Bring cryo-EM into your focus

Image Description
2024-03-01

Cell Cover | Shuimubio Aids in Deciphering Chloroplast Gene Transcription Machinery

Read More
Image Description
2023-02-08

In Silico Discovery of Small Molecule Modulators Targeting the Achilles' Heel of SARS-CoV-2 Spike Protein

Read More
Image Description
2023-01-20

Preprint: Cryo-EM structure of DNA polymerase θ helicase domain in complex with inhibitor novobiocin

Read More
Image Description
2022-09-08

Enrollment List | TOP25 of the 2<SUP>nd</SUP> Young Scientist Cryo-EM Research Support Program

Read More
Image Description
2022-08-18

Preprint: Cryo-EM complex structure of active GPR75 with a nanobody

Read More
Image Description
2022-07-25

2<SUP>nd</SUP> Young Scientist Cryo-EM Research Support Program

Read More
Image Description
2022-04-08

Shuimu will hold booth#2013 during the AACR 2022 event

Read More
Image Description
2022-03-04

Cryo-EM enabled novel and highly differentiated antibody development

Read More
Image Description
2022-03-21

Serial entrepreneur Allen Guo: go beyond boundaries

Read More
Image Description
2022-02-26

NEXT TECH opens, shuimu helps French pharmaceutical companies to innovate in China

Read More
Image Description
2022-02-25

Shuimu, Biocytogen and others collaborate to publish new research paper on COVID19-neutralizing antibody in Cell Discovery

Read More
Image Description
2022-02-25

The second 300kV cryo-EM up and running, apply for Krios G4 free trial now

Read More

Send us a message

Connect with Us. Make Great Things Happen Together.

To inquire about our services, simply fill out this form and we'll be in touch.

See Unseeable.
Drug Undruggable.

Founded in 2017, Shuimu BioSciences aims to bring the power of cryo-EM to innovative therapeutics developers.

Contacts

1 Broadway 5th floor, Cambridge, MA 02142, United States+1 (650) 680 9383

Hi@shuimubio.com

Copyright © 2024 Shuimu Biosciences Ltd.